131 related articles for article (PubMed ID: 23861541)
41. CCAAT/enhancer binding protein delta (C/EBPdelta) expression and elevation in Alzheimer's disease.
Li R; Strohmeyer R; Liang Z; Lue LF; Rogers J
Neurobiol Aging; 2004 Sep; 25(8):991-9. PubMed ID: 15212823
[TBL] [Abstract][Full Text] [Related]
42. CCAAT/enhancer-binding protein delta mediates tumor necrosis factor alpha-induced Aurora kinase C transcription and promotes genomic instability.
Wu SR; Li CF; Hung LY; Huang AM; Tseng JT; Tsou JH; Wang JM
J Biol Chem; 2011 Aug; 286(33):28662-28670. PubMed ID: 21715338
[TBL] [Abstract][Full Text] [Related]
43. Involvement of CCAAT enhancer binding protein transcription factors in the regulation of prostaglandin G/H synthase 2 expression by interleukin-1 in osteoblastic MC3T3-E1 cells.
Harrison JR; Kelly PL; Pilbeam CC
J Bone Miner Res; 2000 Jun; 15(6):1138-46. PubMed ID: 10841183
[TBL] [Abstract][Full Text] [Related]
44. FBXW7α attenuates inflammatory signalling by downregulating C/EBPδ and its target gene Tlr4.
Balamurugan K; Sharan S; Klarmann KD; Zhang Y; Coppola V; Summers GH; Roger T; Morrison DK; Keller JR; Sterneck E
Nat Commun; 2013; 4():1662. PubMed ID: 23575666
[TBL] [Abstract][Full Text] [Related]
45. The prototypic tissue pentraxin PTX3, in contrast to the short pentraxin serum amyloid P, inhibits phagocytosis of late apoptotic neutrophils by macrophages.
van Rossum AP; Fazzini F; Limburg PC; Manfredi AA; Rovere-Querini P; Mantovani A; Kallenberg CG
Arthritis Rheum; 2004 Aug; 50(8):2667-74. PubMed ID: 15334483
[TBL] [Abstract][Full Text] [Related]
46. Pentraxin 3 is an anti-inflammatory protein associated with lipid-induced interleukin 10 in vitro.
Slusher AL; Mischo AB; Acevedo EO
Cytokine; 2016 Oct; 86():36-40. PubMed ID: 27450429
[TBL] [Abstract][Full Text] [Related]
47. Pentraxin-3 is upregulated in the central nervous system during MS and EAE, but does not modulate experimental neurological disease.
Ummenthum K; Peferoen LA; Finardi A; Baker D; Pryce G; Mantovani A; Bsibsi M; Bottazzi B; Peferoen-Baert R; van der Valk P; Garlanda C; Kipp M; Furlan R; van Noort JM; Amor S
Eur J Immunol; 2016 Mar; 46(3):701-11. PubMed ID: 26576501
[TBL] [Abstract][Full Text] [Related]
48. CCAAT/enhancer binding protein δ regulates glial proinflammatory gene expression.
Valente T; Straccia M; Gresa-Arribas N; Dentesano G; Tusell JM; Serratosa J; Mancera P; Solà C; Saura J
Neurobiol Aging; 2013 Sep; 34(9):2110-24. PubMed ID: 23523267
[TBL] [Abstract][Full Text] [Related]
49. The mouse C/EBPdelta gene promoter is regulated by STAT3 and Sp1 transcriptional activators, chromatin remodeling and c-Myc repression.
Zhang Y; Sif S; DeWille J
J Cell Biochem; 2007 Dec; 102(5):1256-70. PubMed ID: 17471507
[TBL] [Abstract][Full Text] [Related]
50. Biological roles of CCAAT/Enhancer-binding protein delta during inflammation.
Ko CY; Chang WC; Wang JM
J Biomed Sci; 2015 Jan; 22(1):6. PubMed ID: 25591788
[TBL] [Abstract][Full Text] [Related]
51. The tumour suppressor C/EBPδ inhibits FBXW7 expression and promotes mammary tumour metastasis.
Balamurugan K; Wang JM; Tsai HH; Sharan S; Anver M; Leighty R; Sterneck E
EMBO J; 2010 Dec; 29(24):4106-17. PubMed ID: 21076392
[TBL] [Abstract][Full Text] [Related]
52. CK2 phosphorylation of C/EBPδ regulates its transcription factor activity.
Schwind L; Zimmer AD; Götz C; Montenarh M
Int J Biochem Cell Biol; 2015 Apr; 61():81-9. PubMed ID: 25680545
[TBL] [Abstract][Full Text] [Related]
53. Genomic analysis of the role of transcription factor C/EBPδ in the regulation of cell behaviour on nanometric grooves.
Wiejak J; Tsimbouri PM; Herzyk P; Dalby MJ; Hamilton G; Yarwood SJ
Biomaterials; 2013 Mar; 34(8):1967-79. PubMed ID: 23245923
[TBL] [Abstract][Full Text] [Related]
54. CCAAT/enhancer-binding protein delta: a molecular target of 1,25-dihydroxyvitamin D3 in androgen-responsive prostate cancer LNCaP cells.
Ikezoe T; Gery S; Yin D; O'Kelly J; Binderup L; Lemp N; Taguchi H; Koeffler HP
Cancer Res; 2005 Jun; 65(11):4762-8. PubMed ID: 15930295
[TBL] [Abstract][Full Text] [Related]
55. Pentraxin-3 Silencing Suppresses Gastric Cancer-related Inflammation by Inhibiting Chemotactic Migration of Macrophages.
Choi B; Lee EJ; Park YS; Kim SM; Kim EY; Song Y; Kang SW; Rhu MH; Chang EJ
Anticancer Res; 2015 May; 35(5):2663-8. PubMed ID: 25964543
[TBL] [Abstract][Full Text] [Related]
56. Transcription factor C/EBPdelta in fetal lung: developmental regulation and effects of cyclic adenosine 3',5'-monophosphate and glucocorticoids.
Breed DR; Margraf LR; Alcorn JL; Mendelson CR
Endocrinology; 1997 Dec; 138(12):5527-34. PubMed ID: 9389540
[TBL] [Abstract][Full Text] [Related]
57. PTX3 binds MD-2 and promotes TRIF-dependent immune protection in aspergillosis.
Bozza S; Campo S; Arseni B; Inforzato A; Ragnar L; Bottazzi B; Mantovani A; Moretti S; Oikonomous V; De Santis R; Carvalho A; Salvatori G; Romani L
J Immunol; 2014 Sep; 193(5):2340-8. PubMed ID: 25049357
[TBL] [Abstract][Full Text] [Related]
58. Detrimental role for CCAAT/enhancer binding protein δ in blood-borne brain infection.
Duitman J; Valls Serón M; Engelen-Lee J; Brouwer MC; Spek CA; van de Beek D
BMC Infect Dis; 2016 Nov; 16(1):670. PubMed ID: 27835970
[TBL] [Abstract][Full Text] [Related]
59. Gene expression profiling identifies C/EBPdelta as a candidate regulator of endotoxin-induced disseminated intravascular coagulation.
Slofstra SH; Groot AP; Obdeijn MH; Reitsma PH; ten Cate H; Spek CA
Am J Respir Crit Care Med; 2007 Sep; 176(6):602-9. PubMed ID: 17600275
[TBL] [Abstract][Full Text] [Related]
60. Regulation of mouse chondrocyte differentiation by CCAAT/enhancer-binding proteins.
Okuma T; Hirata M; Yano F; Mori D; Kawaguchi H; Chung UI; Tanaka S; Saito T
Biomed Res; 2015; 36(1):21-9. PubMed ID: 25749148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
